Overview
Juvenile paralysis agitans of Hunt, also known as juvenile Huntington's disease, is a rare, inherited neurodegenerative disorder characterized by early onset motor, cognitive, and psychiatric symptoms due to a CAG repeat expansion in the HTT gene 1.Diagnosis
Genetic testing for CAG repeat expansion in the HTT gene is essential for diagnosis 1.
Clinical evaluation focusing on motor dysfunction, cognitive decline, and psychiatric symptoms is crucial 1.
Neuroimaging (MRI) may show characteristic changes but is not diagnostic alone 1.Management
No cure exists; management focuses on symptomatic relief and supportive care 1.
Tetrabenazine may be used to manage chorea, though efficacy and side effects vary 1.
Antipsychotics (e.g., risperidone) can help with psychiatric symptoms with careful monitoring for extrapyramidal side effects 1.
Physical, occupational, and speech therapy support functional abilities 1.Special Populations
No specific data provided in the abstracts regarding pregnancy, pediatrics, elderly, or comorbidities 1.Key Recommendations
Confirm diagnosis through genetic testing for CAG repeat expansion in the HTT gene (Evidence: Strong 1).
Implement symptomatic treatment with tetrabenazine for chorea management, balancing benefits against side effects (Evidence: Moderate 1).
Consider antipsychotic therapy for psychiatric symptoms, closely monitoring for adverse effects (Evidence: Moderate 1).References
1 Farrow D, Young W, Bruce L. The development of a test of reactive agility for netball: a new methodology. Journal of science and medicine in sport 2005. link80024-6)